Cipla Ltd.
BSE: 500087 | NSE: CIPLA
Large Cap | Pharmaceuticals & Drugs
1426.80
-11.95 (-0.83%) Cipla - Quaterly Results
Date: 26-10-2021
A minor change in the total revenue was seen in the September 2021 quarter. The total revenue for the quarter stood at Rs. 39350.30 millions against Rs. 38078.90 millions during year ago period.Profit for the quarter ended September 2021 increased merely by4.93% to Rs. 7823.70 millions from Rs. 7456.40 millions.Operating profit surged to 11805.50 millions from the corresponding previous quarter of 11701.40 millions.
(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202109 | 202009 | % Var | 202109 | 202009 | % Var | 202103 | 202003 | % Var | |
| Sales | 39350.30 | 38078.90 | 3.34 | 79524.40 | 69359.10 | 14.66 | 139005.80 | 126591.50 | 9.81 |
| Other Income | 1977.30 | 391.70 | 404.80 | 2773.90 | 848.30 | 227.00 | 2302.80 | 8928.50 | -74.21 |
| PBIDT | 11805.50 | 11701.40 | 0.89 | 24057.00 | 21605.40 | 11.35 | 39518.40 | 36001.40 | 9.77 |
| Interest | 76.00 | 116.90 | -34.99 | 156.00 | 259.00 | -39.77 | 450.70 | 360.50 | 25.02 |
| PBDT | 11729.50 | 11584.50 | 1.25 | 23901.00 | 21346.40 | 11.97 | 39067.70 | 35640.90 | 9.61 |
| Depreciation | 1389.70 | 1408.00 | -1.30 | 2759.50 | 2845.30 | -3.02 | 5561.10 | 5997.80 | -7.28 |
| PBT | 10339.80 | 10176.50 | 1.60 | 21141.50 | 18501.10 | 14.27 | 33506.60 | 29643.10 | 13.03 |
| TAX | 2516.10 | 2720.10 | -7.50 | 5400.10 | 4941.70 | 9.28 | 8823.80 | 6461.40 | 36.56 |
| Deferred Tax | 30.20 | -96.50 | -131.30 | -117.30 | -259.30 | -54.76 | -220.00 | 1001.80 | -121.96 |
| PAT | 7823.70 | 7456.40 | 4.93 | 15741.40 | 13559.40 | 16.09 | 24682.80 | 23181.70 | 6.48 |
| Equity | 1613.30 | 1612.70 | 0.04 | 1613.30 | 1612.70 | 0.04 | 1612.90 | 1612.50 | 0.02 |
| PBIDTM(%) | 30.00 | 30.73 | -2.37 | 30.25 | 31.15 | -2.89 | 28.43 | 28.44 | -0.03 |